Literature DB >> 7698643

Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease.

Z Q Wang1, B Auer, L Stingl, H Berghammer, D Haidacher, M Schweiger, E F Wagner.   

Abstract

Poly(ADP-ribosyl)ation is catalyzed by NAD+: protein(ADP-ribosyl) transferase (ADPRT), a chromatin-associated enzyme which, in the presence of DNA breaks, transfers ADP-ribose from NAD+ to nuclear proteins. This post-translational modification has been implicated in many fundamental processes, like DNA repair, chromatin stability, cell proliferation, and cell death. To elucidate the biological function of ADPRT and poly(ADP-ribosyl)ation in vivo the gene was inactivated in the mouse germ line. Mice homozygous for the ADPRT mutation are healthy and fertile. Analysis of mutant tissues and fibroblasts isolated from mutant fetuses revealed the absence of ADPRT enzymatic activity and poly(ADP-ribose), implying that no poly(ADP-ribosyl)ated proteins are present. Mutant embryonic fibroblasts were able to efficiently repair DNA damaged by UV and alkylating agents. However, proliferation of mutant primary fibroblasts as well as thymocytes following gamma-radiation in vivo was impaired. Moreover, mutant mice are susceptible to the spontaneous development of skin disease as approximately 30% of older mice develop epidermal hyperplasia. The generation of viable ADPRT-/-mice negates an essential role for this enzyme in normal chromatin function, but the impaired proliferation and the onset of skin lesions in older mice suggest a function for ADPRT in response to environmental stress.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7698643     DOI: 10.1101/gad.9.5.509

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  227 in total

Review 1.  The molecular basis of asbestos induced lung injury.

Authors:  D W Kamp; S A Weitzman
Journal:  Thorax       Date:  1999-07       Impact factor: 9.139

Review 2.  Poly(ADP-ribosylation) and apoptosis.

Authors:  A I Scovassi; G G Poirier
Journal:  Mol Cell Biochem       Date:  1999-09       Impact factor: 3.396

3.  Role for caspase-mediated cleavage of Rad51 in induction of apoptosis by DNA damage.

Authors:  Y Huang; S Nakada; T Ishiko; T Utsugisawa; R Datta; S Kharbanda; K Yoshida; R V Talanian; R Weichselbaum; D Kufe; Z M Yuan
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

4.  A cellular defense pathway regulating transcription through poly(ADP-ribosyl)ation in response to DNA damage.

Authors:  S Vispe; T M Yung; J Ritchot; H Serizawa; M S Satoh
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

5.  Involvement of PARP and poly(ADP-ribosyl)ation in the early stages of apoptosis and DNA replication.

Authors:  C M Simbulan-Rosenthal; D S Rosenthal; S Iyer; H Boulares; M E Smulson
Journal:  Mol Cell Biochem       Date:  1999-03       Impact factor: 3.396

6.  DNA strand break-sensing molecule poly(ADP-Ribose) polymerase cooperates with p53 in telomere function, chromosome stability, and tumor suppression.

Authors:  W M Tong; M P Hande; P M Lansdorp; Z Q Wang
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

7.  Base excision repair is efficient in cells lacking poly(ADP-ribose) polymerase 1.

Authors:  M D Vodenicharov; F R Sallmann; M S Satoh; G G Poirier
Journal:  Nucleic Acids Res       Date:  2000-10-15       Impact factor: 16.971

8.  Poly(ADP-ribose)polymerase-1 (PARP1) controls adipogenic gene expression and adipocyte function.

Authors:  Süheda Erener; Mareike Hesse; Radina Kostadinova; Michael O Hottiger
Journal:  Mol Endocrinol       Date:  2011-11-03

Review 9.  Fine tuning chemotherapy to match BRCA1 status.

Authors:  Melissa Price; Alvaro N A Monteiro
Journal:  Biochem Pharmacol       Date:  2010-05-25       Impact factor: 5.858

10.  Noncleavable poly(ADP-ribose) polymerase-1 regulates the inflammation response in mice.

Authors:  Virginie Pétrilli; Zdenko Herceg; Paul O Hassa; Nimesh S A Patel; Rosanna Di Paola; Ulrich Cortes; Laura Dugo; Helder-Mota Filipe; Christoph Thiemermann; Michael O Hottiger; Salvatore Cuzzocrea; Zhao-Qi Wang
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.